The DOI matches its Crossref record.
Treatment of hydatid disease in childhood with mebendazole
Abstract
The general characteristics of 56 childhood cases of cystic hydatid disease were analysed and the results of mebendazole therapy versus surgery were verified. Pulmonary radiograms and ultrasonography were used in the diagnosis. The cysts were localized primarily to the lungs. Twenty seven patients were surgically-treated, with eight having recurrence after a mean period of 3.6 yrs. Thirty patients received regular mebendazole treatment, in a dose of 50 mg.kg-1 with a mean duration of treatment of 11.7 months. Twenty one patients were cured and discontinued the therapy. Nine still use the drug, seven of whom have had dramatic improvement, while the other two have minimal radiographic changes but subjective improvement in general condition. The lung cysts vanished leaving minimal scars, whilst the liver cysts turned into inactive forms. The surgically-treated and drug-treated groups were similar in age, duration and severity of the disease. The recurrence rate of drug-treated children (1 out of 20) was lower than that of the surgically-treated children (8 out of 27); however, this was not statistically significant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In children with cystic echinococcosis, mebendazole (50 mg/kg daily for 9-18 months) was appropriate to use due to lack of side effects, high therapeutic effects, and low risk of recurrence.
“in children, mebendazole (50 mg/kg daily for 9–18 months) was appropriate to use due to the lack of side effects, high therapeutic effects, and low risk of recurrence [186]”
From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [186]
In children patients with hydatid disease, even long-term mebendazole treatment (50 mg/kg daily for 9-18 months) was safe without significant side effects.
“However, in children patients with hydatid disease, even long-term mebendazole treatment (50 mg/kg daily for 9–18 months) was safe without significant side effects [186].”
From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [186]
Citations
Cited by
Sorted by citations
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286
Metadata
- Authors
- Gocmen, A., Toppare, M., & Kiper, N.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 1993-02-01
- Volume
- 6
- Issue
- 2
- Pages
- 253-257
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W1926776606
- Cited by
- 36
- References
- 0
- Citations by year
- 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2015: 1 · 2013: 1 · 2012: 3
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasitic infections in humans and animals
- Life Sciences › Immunology and Microbiology › Parasitology › Helminth infection and control
- Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
- Keywords
- echinococcosis, mebendazole, pediatric patients, antiparasitic chemotherapy, surgical treatment, recurrence, pulmonary hydatid cyst, hepatic hydatid cyst
- MeSH terms
- Adolescent, Child, Child, Preschool, Echinococcosis, Hepatic, Echinococcosis, Pulmonary, Follow-Up Studies, Humans, Mebendazole, Recurrence, Time Factors, Turkey
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review